Literature DB >> 12390252

lal-1: a differentially expressed novel gene during proliferation in liver regeneration and in hepatoma cells.

Maria Agnese Della Fazia1, Danilo Piobbico, Daniela Bartoli, Marilena Castelli, Stefano Brancorsini, Mariapia Viola Magni, Giuseppe Servillo.   

Abstract

BACKGROUND: During liver regeneration, 95% of the resting hepatocytes enter in G1/S phase of the cell cycle. A number of hormones, growth factors and cytokines were identified that activate signal transduction pathways playing a primary role in hepatocyte proliferation. A wide and representative cDNA library containing 1.5 x 106 independent clones was constructed from regenerating liver in order to identify and characterize gene the products which play a crucial role in the first hours of the proliferative process of liver regeneration.
RESULTS: A novel gene expressed in liver regeneration was cloned by subtractive hybridization. The putative protein displays in the N'-terminal a annexin-like domain and an aminopeptidase domain. We named the novel gene Liver Annexin Like-1 (lal-1). The lal-1 gene is modulated during liver regeneration, in hepatoma cells following physiological stimulation and after cAMP induction.
CONCLUSION: The results indicate that lal-1 is involved in liver regeneration and that its expression is finely regulated during proliferative process. The isolation of lal-1 paves the way for a further characterization helping to assess lal-1 involvement in cell function and proliferation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390252     DOI: 10.1046/j.1365-2443.2002.00593.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  7 in total

1.  Different functions of HOPS isoforms in the cell: HOPS shuttling isoform is determined by RIP cleavage system.

Authors:  Marilena Castelli; Danilo Piobbico; Daniela Bartoli; Stefania Pieroni; Cinzia Brunacci; Marina Maria Bellet; Martina Chiacchiaretta; Maria Agnese Della Fazia; Giuseppe Servillo
Journal:  Cell Cycle       Date:  2013-02-01       Impact factor: 4.534

2.  Impaired cell proliferation in regenerating liver of 3 β-hydroxysterol Δ14-reductase (TM7SF2) knock-out mice.

Authors:  Daniela Bartoli; Danilo Piobbico; Marina Maria Bellet; Anna Maria Bennati; Rita Roberti; Maria Agnese Della Fazia; Giuseppe Servillo
Journal:  Cell Cycle       Date:  2016-06-24       Impact factor: 4.534

3.  NEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells.

Authors:  Marina Maria Bellet; Danilo Piobbico; Daniela Bartoli; Marilena Castelli; Stefania Pieroni; Cinzia Brunacci; Martina Chiacchiaretta; Rachele Del Sordo; Francesca Fallarino; Angelo Sidoni; Paolo Puccetti; Luigina Romani; Giuseppe Servillo; Maria Agnese Della Fazia
Journal:  Cell Cycle       Date:  2014-04-17       Impact factor: 4.534

Review 4.  HOPS and p53: thick as thieves in life and death.

Authors:  Maria Agnese Della-Fazia; Marilena Castelli; Danilo Piobbico; Stefania Pieroni; Giuseppe Servillo
Journal:  Cell Cycle       Date:  2020-10-28       Impact factor: 4.534

5.  Biomarker discovery for chronic liver diseases by multi-omics - a preclinical case study.

Authors:  Daniel Veyel; Kathrin Wenger; Andre Broermann; Tom Bretschneider; Andreas H Luippold; Bartlomiej Krawczyk; Wolfgang Rist; Eric Simon
Journal:  Sci Rep       Date:  2020-01-28       Impact factor: 4.379

6.  HOPS/Tmub1 involvement in the NF-kB-mediated inflammatory response through the modulation of TRAF6.

Authors:  Marina Maria Bellet; Stefania Pieroni; Marilena Castelli; Danilo Piobbico; Francesca Fallarino; Luigina Romani; Maria Agnese Della-Fazia; Giuseppe Servillo
Journal:  Cell Death Dis       Date:  2020-10-15       Impact factor: 8.469

7.  HOPS/TMUB1 retains p53 in the cytoplasm and sustains p53-dependent mitochondrial apoptosis.

Authors:  Marilena Castelli; Danilo Piobbico; Martina Chiacchiaretta; Cinzia Brunacci; Stefania Pieroni; Daniela Bartoli; Marco Gargaro; Francesca Fallarino; Paolo Puccetti; Silvia Soddu; Maria Agnese Della-Fazia; Giuseppe Servillo
Journal:  EMBO Rep       Date:  2019-12-23       Impact factor: 8.807

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.